Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1448009

Cover Image

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1448009

Feed Antibiotics Market - 2023-2030

PUBLISHED:
PAGES: 181 Pages
DELIVERY TIME: 2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4350
PDF & Excel (Multiple User License)
USD 4850
PDF & Excel (Enterprise License)
USD 7850

Add to Cart

Overview

Global Feed Antibiotics Market reached US$ 2.80 billion in 2022 and is expected to reach US$ 3.92 million by 2030, growing with a CAGR of 4.3% during the forecast period 2023-2030.

Growing global populations and increasing income levels in many regions were leading to higher meat and dairy consumption. According to FAO, worldwide per capita meat consumption is expected to rise by 0.3% pa to 35.4 kg in retail weight equivalent by 2030. As a result, there is a greater demand for animal feed, including antibiotics to promote livestock growth and health.

Feed antibiotics were commonly employed to boost livestock growth rates and improve feed efficiency in animal farming. By promoting faster growth and efficient nutrient utilization, farmers could meet the increasing global demand for meat and animal products more effectively. This practice aimed to maximize productivity within intensive farming systems. Hence, rising awareness about the benefits of using feed antibiotics acts as a key trend for boosting market growth.

Tetracyclines play a crucial role in the global feed antibiotics market, constituting a significant one-third share due to their widespread use for promoting livestock growth and preventing diseases. At the same time, the Asia-Pacific region holds an equally substantial one-third share, mainly driven by the increasing demand for meat and dairy products. According to China Briefing, with an average per capita consumption of over 53 million tons of pork and 10 million tons of beef and veal, China was among the world's largest meat consumers in 2022.

Dynamics

Rising Demand for Animal-derived Food Products

There is a rising demand for meat, dairy, and eggs, as global populations grow and incomes rise. According to FAO, the consumption of animal proteins worldwide is anticipated to increase by 14% between 2018 and 2030. By 2030, it is anticipated that the protein available from meat from sheep, beef, pork, and poultry will increase by 17.8%, 5.9%, 13.1%, and 15.7%, respectively. To keep these animals healthy and promote growth, many farmers have historically used antibiotics as feed additives which drives its demand.

Antibiotics in animal agriculture serve a multifaceted role, promoting growth, preventing diseases, and facilitating treatment. The crowded and stressful conditions of industrial farming create an environment where diseases can quickly spread among animals. Antibiotics help prevent these diseases and reduce livestock mortality rates, ensuring a stable supply of animal-derived food products. Farmers benefit from this efficiency as it reduces the time and resources needed to raise animals for food.

Increasing Investment in Animal Health Expenditure

Governments and private investors are increasingly recognizing the importance of the livestock sector and are investing in modernizing livestock production facilities enhancing animal health management etc. In February 2020, Elanco Animal Health Incorporated announced an agreement with Merck Animal Health to transfer worldwide rights for the Vecoxan for USD 55 million in an all-cash arrangement. Vecoxan is used for the prevention and treatment of coccidiosis in calves and lambs. These types of investments in turn drive the feed antibiotics market growth

Antibiotics are crucial in animal feed for preventing and managing diseases. Healthy animals not only grow faster but also produce more efficiently, which is essential to meet the growing demand for animal products. Antibiotics play a vital role in minimizing disease outbreaks in densely populated livestock facilities, resulting in improved overall health and higher productivity levels. Hence with the growing consumer awareness of animal welfare, and antibiotic use in livestock there is a growing demand for products from animals raised with responsible antibiotic use.

Growing Resistance to Antibiotics

Overuse and misuse of antibiotics, including their use in animal agriculture, have led to the development of antibiotic-resistant bacteria. These resistant pathogens can infect animals and have the potential to transfer to humans through the food chain or environmental contamination, creating a significant public health risk. The American Meat Institute claims that eating meat from an animal that has received antibiotic treatment results in human antimicrobial resistance (resistance to certain antibiotics).

Regulatory bodies worldwide are increasingly concerned about antibiotic resistance and its impact on human health. Consequently, many countries have introduced stricter regulations governing antibiotic use in livestock farming. For instance, on January 28, 2022, the European Union implemented a new law prohibiting the routine feeding of antibiotics to farmed animals. Such regulations often restrict the types of antibiotics that can be employed, thereby constraining the growth of the antibiotic market in animal agriculture.

Segment Analysis

The global feed antibiotics market is segmented based on type, animal, mode of delivery, end-user and region.

Rising Demand Tetracyclines for Effectiveness against Various Bacteria

Tetracyclines, a class of antibiotics known for their wide-ranging effectiveness against various bacteria, play a crucial role in preventing and treating bacterial infections in animals. They excel in managing respiratory, gastrointestinal, and skin infections in animals. Regulatory agencies, including the FDA, have approved numerous tetracycline antibiotics for use in animal agriculture, underscoring their safety and suitability for this purpose. This regulatory approval instills confidence in their safety and efficacy.

Tetracyclines have a long history of successful use in veterinary medicine. Their effectiveness in controlling and preventing. Their versatile administration methods, including through feed, water, or injections, provide farmers with the flexibility to cater to the specific needs of animals and the diseases they face, making them a convenient and trusted option.

Source: DataM Intelligence Analysis (2023)

Geographical Penetration

Asia-Pcific's Growing Feed Industry

The region has embraced modern and intensive farming practices to maximize animal production efficiency. According to a study published in February 2020 by Dongguan University of Technology, Dongguan, China, in-feed antibiotic use altered behaviors of Oxytetracycline, sulfamerazine, and ciprofloxacin, as well as related antibiotic resistance genes during the composting of swine manure.

Asia-Pacific has experienced significant population growth, urbanization, and rising incomes. This has led to increased demand for animal-based protein products, such as meat, milk, and eggs. The Department of Animal Husbandry and Dairying reports that India is the world's top producer of milk. Milk production increased by 5.81% annually between 2019-2020 and 2020-21, reaching 198.44 million tonnes and 209.96 million tonnes, respectively. This rising demand for animal-derived products needs large amounts of feed antibiotics.

Key players in the feed and agriculture sectors have established a strong presence in the Asia Pacific, boosting market growth. The key players of feed antibiotics present in Asia-Pacific are Bayer Health Care AG, Virbac Animal Health, Merck Animal Health, Elanco Animal Health, etc. These companies are investing in R&D infrastructure and continuously introducing various feed additives including feed yeast. Hence, the presence of major companies acts as a key trend for the feed yeast market growth in that region.

Source: DataM Intelligence Analysis (2023)

Competitive Landscape

The major global players include Merck & Co., Inc, Zoetis Services LLC, Virbac, Phibro Animal Health Corporation, Vetoquinol, Ceva, Kyoritsuseiyaku Corporation, Inovet, MEGAMIX and Dechra Pharmaceuticals PLC.

COVID-19 Impact Analysis

COVID Impact

The pandemic disrupted global supply chains, affecting the production and distribution of feed antibiotics. This led to shortages and delays in the availability of feed antibiotics in some regions, impacting farmers' ability to maintain animal health. COVID-19 heightened consumer awareness of food safety and hygiene. This led to increased demand for products from animals raised with responsible antibiotic use or raised without antibiotics. As a result, some farmers and producers shifted towards antibiotic-free or reduced-antibiotic practices.

Concerns about antibiotic resistance have led to increased regulatory scrutiny of antibiotic use in animal agriculture. Some regions implemented stricter regulations during the pandemic, further influencing antibiotic use practices in livestock. The economic challenges brought by the pandemic, including reduced demand for certain animal products and increased production costs, made farmers more conscious of their expenses. This prompted some to reevaluate their antibiotic use and explore cost-effective alternatives.

Russia- Ukraine War Impact

Ukraine is a significant producer of agricultural commodities, including grains and animal feed ingredients. The conflict has disrupted the agricultural supply chain in the region, potentially affecting the availability and prices of feed ingredients used in animal agriculture, including those related to feed antibiotics. The conflict disrupted international trade routes and agreements, affecting the export and import of animal products and feed ingredients.

The war has led to economic instability in Ukraine and neighboring regions. Economic uncertainties affect consumer demand for animal products, which in turn can influence the production practices and antibiotic use in animal agriculture. As a response to supply chain disruptions caused by the conflict, some regions or countries may seek to diversify their sources of feed ingredients and animal products. This diversification can impact the distribution and use of feed antibiotics.

By Type

  • Tetracyclines
  • Penicillins
  • Sulfonamides
  • Macrolides
  • Aminoglycosides
  • Cephalosporins
  • Others

By Animal

  • Ruminants
  • Poultry
  • Swine
  • Aquaculture
  • Horses
  • Pets
  • Others

By Mode of Delivery

  • Premixes
  • Oral Powder
  • Oral Solution
  • Injection
  • Others

By End-User

  • Veterinary Hospitals
  • Homecare
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In July 2022, Virbac, dedicated to animal health, introduced TENOTRYL (enrofloxacin) injectable solution in the United States and expanded its product line to offer veterinarians and their clients, cattle and swine producers, a strong bench of new alternatives to enhance the health of livestock and, ultimately, their profitability.
  • In November 2021, Kemin, a manufacturer of ingredients for several industries, including human/animal health and nutrition, pet food, aquaculture etc. introduced a new product in Europe called TOXFIN CARE. This product was designed to protect animal organs and tissue from potential mycotoxin harm to prevent performance and productivity loss.
  • In July 2020, Trianni and Zoetis, an animal health company, announced an agreement, to create a transgenic antibody discovery platform for use in animal health.

Why Purchase the Report?

  • To visualize the global feed antibiotics market segmentation based on type, animal, mode of delivery, end-user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of Feed Antibiotics market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global feed antibiotics market report would provide approximately 77 tables, 69 figures and 181 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies
Product Code: AG8033

Table of Contents

Table of Contents

1.Methodology and Scope

  • 1.1.Research Methodology
  • 1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

  • 3.1.Snippet by Type
  • 3.2.Snippet by Animal
  • 3.3.Snippet by Mode of Delivery
  • 3.4.Snippet by End-user
  • 3.5.Snippet by Region

4.Dynamics

  • 4.1.Impacting Factors
    • 4.1.1.Drivers
      • 4.1.1.1.Rising Demand for Animal-derived Food Products
      • 4.1.1.2.Increasing Investment in Animal Health Expenditure
    • 4.1.2.Restraints
      • 4.1.2.1.Growing Resistance to Antibiotics
    • 4.1.3.Opportunity
    • 4.1.4.Impact Analysis

5.Industry Analysis

  • 5.1.Porter's Five Force Analysis
  • 5.2.Supply Chain Analysis
  • 5.3.Pricing Analysis
  • 5.4.Regulatory Analysis

6.COVID-19 Analysis

  • 6.1.Analysis of COVID-19
    • 6.1.1.Scenario Before COVID
    • 6.1.2.Scenario During COVID
    • 6.1.3.Scenario Post COVID
  • 6.2.Pricing Dynamics Amid COVID-19
  • 6.3.Demand-Supply Spectrum
  • 6.4.Government Initiatives Related to the Market During Pandemic
  • 6.5.Manufacturers Strategic Initiatives
  • 6.6.Conclusion

7.By Type

  • 7.1.Introduction
    • 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2.Market Attractiveness Index, By Type
  • 7.2.Tetracyclines*
    • 7.2.1.Introduction
    • 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3.Penicillins
  • 7.4.Sulfonamides
  • 7.5.Macrolides
  • 7.6.Aminoglycosides
  • 7.7.Cephalosporins
  • 7.8.Others

8.By Animal

  • 8.1.Introduction
    • 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal
    • 8.1.2.Market Attractiveness Index, By Animal
  • 8.2.Ruminants*
    • 8.2.1.Introduction
    • 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3.Poultry
  • 8.4.Swine
  • 8.5. Aquaculture
  • 8.6.Horses
  • 8.7.Pets
  • 8.8.Others

9.By Mode of Delivery

  • 9.1.Introduction
    • 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 9.1.2.Market Attractiveness Index, By Mode of Delivery
  • 9.2.Premixes*
    • 9.2.1.Introduction
    • 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3.Oral Powder
  • 9.4.Oral Solution
  • 9.5.Injection
  • 9.6.Others

10.By End-User

  • 10.1.Introduction
    • 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2.Market Attractiveness Index, By End-User
  • 10.2.Veterinary Hospitals*
    • 10.2.1.Introduction
    • 10.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3.Homecare
  • 10.4.Others

11.By Region

  • 11.1.Introduction
    • 11.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2.Market Attractiveness Index, By Region
  • 11.2.North America
    • 11.2.1.Introduction
    • 11.2.2.Key Region-Specific Dynamics
    • 11.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal
    • 11.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 11.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1.U.S.
      • 11.2.7.2.Canada
      • 11.2.7.3.Mexico
  • 11.3.Europe
    • 11.3.1.Introduction
    • 11.3.2.Key Region-Specific Dynamics
    • 11.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal
    • 11.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 11.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1.Germany
      • 11.3.7.2.UK
      • 11.3.7.3.France
      • 11.3.7.4.Italy
      • 11.3.7.5.Russia
      • 11.3.7.6.Rest of Europe
  • 11.4.South America
    • 11.4.1.Introduction
    • 11.4.2.Key Region-Specific Dynamics
    • 11.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal
    • 11.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 11.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1.Brazil
      • 11.4.7.2.Argentina
      • 11.4.7.3.Rest of South America
  • 11.5.Asia-Pacific
    • 11.5.1.Introduction
    • 11.5.2.Key Region-Specific Dynamics
    • 11.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal
    • 11.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 11.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1.China
      • 11.5.7.2.India
      • 11.5.7.3.Japan
      • 11.5.7.4.Australia
      • 11.5.7.5.Rest of Asia-Pacific
  • 11.6.Middle East and Africa
    • 11.6.1.Introduction
    • 11.6.2.Key Region-Specific Dynamics
    • 11.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal
    • 11.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 11.6.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12.Competitive Landscape

  • 12.1.Competitive Scenario
  • 12.2.Market Positioning/Share Analysis
  • 12.3.Mergers and Acquisitions Analysis

13.Company Profiles

  • 13.1.Merck & Co., Inc.*
    • 13.1.1.Company Overview
    • 13.1.2.Product Portfolio and Description
    • 13.1.3.Financial Overview
    • 13.1.4.Recent Developments
  • 13.2.Zoetis Services LLC.
  • 13.3.Virbac.
  • 13.4.Phibro Animal Health Corporation
  • 13.5.Vetoquinol
  • 13.6.Ceva
  • 13.7.Kyoritsuseiyaku Corporation
  • 13.8.Inovet
  • 13.9.MEGAMIX
  • 13.10.Dechra Pharmaceuticals PLC LIST NOT EXHAUSTIVE

14.Appendix

  • 14.1.About Us and Services
  • 14.2.Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!